Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | C149 - Mild Cognitive Impairment/Subjective Cognitive Impairment

Thursday 04/07/22
07:00 AM - 09:00 AM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Ronald C. Petersen, PhD, MD, FAAN
Aging, Dementia, Cognitive, and Behavioral Neurology
Participants should understand current practice of diagnosing mild cognitive impairment; apply the diagnosis of mild cognitive impairment to clinical practice; employ reasonable evaluation strategy for persons with MCI; analyze data regarding the typical and atypical etiologies of the syndrome of MCI; and evaluate potential treatments for MCI in the setting of disease modifying therapies for Alzheimer's disease.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement
Advanced
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:30 AM PDT Speaker Overview of Mild Cognitive Impairment
Ronald C. Petersen, PhD, MD, FAAN
07:00 AM - 07:00 AM PDT Speaker Walk-in Slides
Ronald C. Petersen, PhD, MD, FAAN
07:30 AM - 07:50 AM PDT Speaker Atypical Forms of MCI
Oscar L. Lopez, MD, FAAN
07:50 AM - 08:20 AM PDT Speaker Treatments for MCI
David J. Gill, MD, FAAN
08:20 AM - 09:00 AM PDT Discussion Case Studies of MCI
Ronald C. Petersen, PhD, MD, FAAN, Oscar L. Lopez, MD, FAAN, David J. Gill, MD, FAAN
Faculty Disclosures
Ronald C. Petersen, PhD, MD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc.. Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Inc.. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Oscar L. Lopez, MD, FAAN Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck.
David J. Gill, MD, FAAN Dr. Gill has nothing to disclose.